510(k) K213255

CipherOx CRI Tablet by Flashback Technologies, Inc. — Product Code PPW

K213255 is an FDA 510(k) premarket notification submitted by Flashback Technologies, Inc. for the device "CipherOx CRI Tablet". The FDA issued a decision of Substantially Equivalent on Jun 17, 2022. The device falls under product code PPW (Adjunctive Cardiovascular Status Indicator), a Class II device regulated under 21 CFR 870.2200. Flashback Technologies, Inc. has 2 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jun 17, 2022
Date Received
Sep 30, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Adjunctive Cardiovascular Status Indicator
Device Class
Class II
Regulation Number
870.2200
Review Panel
CV
Submission Type
510(k)

The adjunctive cardiovascular status indicator is a prescription device based on sensor technology for the measurement of a physical parameter(s). This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.

Need the full FDA record for Flashback Technologies, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K213255. Report a data issue: hello@regdatalab.com.